Legal News

The revision emphasizes training and competency of pharmacists.

The risk for fatal medication errors is highlighted in an important new warning within a revised produt label for Heparin Sodium Injection.

Nine Miami defendants in strike force cases sentenced for Medicare fraud

To settle a suit filed by New Jersey authorities, two online pharmacies must pay a fee and stop dispensing drugs to state residents

Bill seeks to prohibit cigarette sales in New York supermarkets with pharmacies

Some pharmacists feel that record-keeping is unduly burdensome and the process has not reduced the production of methamphetamines.

DEA issues new rules governing schedule II narcotics prescriptions and forms and suspends the license for two Cardinal Healthcare distrubtion centers.

At its 2008 midyear meeting, ASHP reemphasized its intent to push for the accreditatin of technician training programs and postgraduate training of residents.

Most Medicare providers and beneficiaries are unaware of the provision for comparative effectiveness research which is part of the Medicare Modernization Act. Politicians, policymakers, and manufacturers view it as a key initiative for the future of Medicare and beyond.

CMS announces accreditation deadlines for Part B DMEPOS suppliers

New rule requires pharmacies to provide patients with a toll-free number to report adverse events.

NACDS and NCPA win a key victory in their legal battle against the AMP rule when a federal judge issued a preliminary injunction against CMS

DEA proposes a rule that would create a new format for ordering Schedule I and/or II controlled substances.

Hospitals will not have to deduct pharmacy overhead costs from drug acquisition costs on Medicare claims, nor will they have to report overhead charges as a separate billing line item. However, CMS refused to back off its proposal to cut the 2008 reimbursement rate for all separately payable drugs.

The idea of a major new center to support studies comparing drugs and other medical interventions in head-to-head research has gained surprising focus in health policy discussions.

Participants at a recent roundtable meeting, including government and industry representatives, agreed to move forward with creating a forum on standardizing prescription medication labels.

Make the Road New York protests pharmacies for not providing translation services.

A pharmacist and health food store owner challenges the ruling by the Tennessee Board of Medical Examiners that he was improperly acting as a doctor when he recommended OTCs for diseases

There are several reforms for emergency preparedness in the workds that could affect pharmacists.

The FDA has approved a new treatment for anthracycline extravasation. Totect is indicated for the treatment of extravasations resulting from IV anthracycline chemotherapy.

Pharmacy organizations celebrate American Pharmacists Month and look to raise awareness of the pharmacist's role in healthcare.

The Food and Drug Administration most emphatically is not against compounding of drugs, Steven Silverman, a key enforcement officer in that agency, told the National Association of Boards of Pharmacy recently.

Advice on the area of collaborative drug therapy managment.

The International Pharmaceutical Federation addressed progress in identifying and dealing with issues related to ersatz (or replacement) drug products.

The Centers for Medicare and Medicaid Services moves fowarded with implementing new tamper-restantant prescription pad rules.

DEA proposes self-certification fee for sellers of scheduled listed chemical products

California pharmacy board is stepping up its enforcement of its pharmacy consultation with stiffer fines.

The Senate passed legislation delaying implementation of the Medicaid rule mandating tamper-resistant Rx pads and awaits House action.

FDA's proposal for new sunscreen regulations address UVA rays as well as other measures consumers may take to protect themselves from UVB rays.

Medicare Part D was a remarkable development, not only for establishing a prescription drug benefit but for giving consumers more responsibility for their insurance and prescription purchase decisions.